EpiBone
A revolutionary bone reconstruction company that grows living bone tissue from patients' own cells.
Launch date
Employees
Market cap
-
Enterprise valuation
€67—101m (Dealroom.co estimates Dec 2022.)
New York City New York (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$150k | Grant | ||
| N/A | N/A | Grant | |
| N/A | N/A | Seed | |
N/A | Early VC | ||
$560k | Convertible | ||
| N/A | N/A | Grant | |
$1m | Grant | ||
N/A | Seed | ||
| N/A | N/A | Early VC | |
* | N/A | $750k | Debt |
* | $1.0m | Seed | |
* | N/A | $18.5m | Late VC |
| Total Funding | €19.3m | ||
Related Content
Recent News about EpiBone
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.